| 000 | 00931 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512033638.0 | ||
| 264 | 0 | _c19901012 | |
| 008 | 199010s 0 0 eng d | ||
| 022 | _a0921-4410 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Incalci, M | |
| 245 | 0 | 0 |
_aPodophyllotoxin derivatives VP-16 and VM-26. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and biological response modifiers _c1987 |
||
| 300 |
_a67-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDrug Resistance _xphysiology |
| 650 | 0 | 4 |
_aEtoposide _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTeniposide _xadverse effects |
| 700 | 1 | _aGarattini, S | |
| 773 | 0 |
_tCancer chemotherapy and biological response modifiers _gvol. 9 _gp. 67-70 |
|
| 999 |
_c3085222 _d3085222 |
||